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Abstract
Tobacco cessation interventions developed and evaluated for Alaska Native 
women do not exist.  As part of routine clinical care provided at a prenatal 
visit, a brief tobacco educational intervention for Alaska Native pregnant 
women (N=100; mean ± SD age = 25.9±6.2 years; mean 6.3± 2.6 months 
gestation) was piloted at the Y-K Delta Regional Hospital in Bethel, Alaska.  
This retrospective study reports on the evaluation of this clinical program.  
The intervention was consistent with the clinical practice guidelines (i.e., 5 A’s 
– ask, advise, assess, assist, arrange), with an average duration of 20.2 ± 6.8 
minutes.  The self-reported tobacco abstinence rate following the interven-
tion was 11% at the last prenatal visit and 12% at delivery.  Delivering a to-
bacco cessation intervention at a prenatal visit is feasible, but there is a need 
to identify more effective interventions for Alaska Native pregnant women.  
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Introduction
Reducing tobacco use during pregnancy among Alaska Native women is 
a national public health priority (Fiore et al., 2008).  In 2000, cigarette smoking 
during pregnancy was most prevalent among American Indian and Alaska 
Native women (20%) followed by non-Hispanic Whites (16%), non-Hispanic 
Blacks (9%) and Hispanic women (4%) (Martin, Hamilton, Ventura, Menacker, 
& Park, 2002).  Overall the percentage of U.S. women reporting smokeless 
tobacco (ST) use during pregnancy is very low (<1%) (Substance Abuse and 
Mental Health Services Administration, 2006).  Among Alaska Native women 
residing in the Yukon-Kuskokwim (Y-K) Delta of Western Alaska, between 
76-79% use ST or smoke cigarettes during pregnancy (Hurt et al., 2005; 
Patten et al., 2008 in press; Renner et al., 2004).   However, tobacco cessation 
interventions developed for Alaska Native women do not exist (Melvin & 
Gaffney, 2004; USDHHS, 2001)  Moreover, aside from our qualitative work 
(Renner et al., 2004), health beliefs related to tobacco use during pregnancy 
have not been assessed among Alaska Native women.  
The most common form of ST used in Western Alaska is known as Iqmik, a 
mixture of fire-cured tobacco leaves and fungus ash.  Iqmik is most commonly 
prepared by women, who mix the ash with tobacco leaves and then pre-
chew it, or mix it in a bowl with water where it is cut and stirred with a knife.  
Iqmik and other tobacco products are not used ceremonially by Alaska Native 
people (Blanchette, 2001).  Because of the high pH (10.9) of the fungus ash, 
almost 100% of the nicotine in Iqmik is in the freebase form (Renner, Enoch 
et al., 2005).  This allows for rapid absorption of nicotine across the buccal 
mucosal membrane, which likely contributes to the addictive properties of 
Iqmik.  Among 60 pregnant Alaska Native women of this region, we found 
that those reporting only Iqmik use during the seven days prior to delivery 
had significantly higher mean concentrations of cotinine in maternal blood 
and infant cord blood compared with women who used other tobacco 
products or reported abstinence from tobacco (Hurt et al., 2005).  Our findings 
also indicated that neonates born to mothers using only Iqmik experienced 
greater adverse neurobehavioral effects (e.g., irritability) than the neonates 
born to women who reported using other tobacco products or no tobacco 
use.  Nonetheless, our prior qualitative work suggests a lack of knowledge 
about the potential health effects of Iqmik use during pregnancy (Renner et 
al., 2004).  
In samples of non-Alaska Native pregnant women who smoke cigarettes, 
most are aware that smoking during pregnancy could be deleterious to the 
outcome of their pregnancy (USDHHS, 2001), that is, between 68-75% report 
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that smoking could have adverse pregnancy outcomes and 61-93% perceive 
that smoking is harmful to the fetus (Arnold et al., 2001; Dunn, Pirie, & Lando, 
1998; Gawley & Cupples, 2002; Lelong, Kaminski, Chwalow, Bean, & Subtil, 
1995; Walsh, Redman, Brinsmead, & Fryer, 1997).  Unfortunately, these health 
beliefs are not highly correlated with smoking cessation during pregnancy 
(Acharya, Jauniaux, Sathia, Griffin, & Morgan, 2002; Arnold et al., 2001; Haslam, 
Draper, & Goyder, 1997).  That is, most research indicates that the beliefs of 
women who quit are similar to those who continue to smoke.  However, some 
studies suggest that continuing smokers are less likely to perceive adverse 
health effects of smoking during pregnancy than women who stop smoking 
(Haslam & Draper, 2000).  
The state-of-the-art intervention for pregnant women (Windsor et al., 
2000) consists of a brief (5-minute) cessation counseling session delivered by 
a trained provider and the provision of pregnancy specific, self-help materials.  
There are five components (5A’s) of the recommended method: ask, advise, 
assess, assist, and arrange (Fiore et al., 2008; Melvin et al., 2000).  A meta-
analysis performed of 34 intervention trials during pregnancy found the mean 
rate of smoking cessation was 16% for intervention groups versus 9% for 
control groups (Lumley, Oliver, Chamberlain, & Oakley, 2004).   
Building on our successful partnership and previous work with the 
Alaska Native community (Enoch & Patten, 2004; Renner, Enoch et al., 2005), 
this retrospective study represents an initial step in developing targeted 
tobacco cessation interventions for pregnant Alaska Native women.  As part 
of routine clinical care provided at the first prenatal visit, the Nicotine Control 
and Research Program at the Y-K Delta Regional Hospital in Bethel, Alaska, 
piloted a brief tobacco educational intervention for pregnant women.  This 
retrospective study reports on the evaluation of this clinical program. Our 
aims were to: (1) describe the baseline (i.e., prior to the intervention) socio-
demographics, tobacco use characteristics, and tobacco-related health beliefs; 
(2) compare these baseline variables by type of tobacco used; and (3) examine 
maternal tobacco use status following the educational intervention at the last 
prenatal visit and at delivery.   
Methods
This study was approved by the Yukon-Kuskokwim Health Corporation 
(YKHC) Human Studies Committee and Board of Directors, Alaska Native Tribal 
Health Consortium Board of Directors, Alaska Native Area Health Service IRB, 
and the Mayo Clinic IRB. 
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Study Design
A retrospective review of a clinical database and medical records was 
performed.  Counselors were trained on the delivery of the intervention and 
data collection procedures.  The intervention was piloted with 100 women 
seen for prenatal care over a 10-month period in 2002.  All intervention data 
were entered by counselors into an electronic database.  Obstetrical staff 
routinely assesses tobacco use at the week 36 visit and at delivery and these 
data are entered into the patient’s medical record.     
Study Setting
The Y-K Delta covers an area in Western Alaska about the size of the 
state of Ohio.  The village of Bethel (population 6,000) is the regional 
hub for the villages comprising Western Alaska.  Approximately 94% of 
the regional population outside of Bethel is made up of Alaska Native 
people-- predominantly Yup’ik or Cup’ik.  The Y-K Delta population of 
25,000 is extremely young (current median age is 23.5 years), and with low 
socioeconomic status (Alaska Humanities Forum, 2003).  Most of the residents 
live largely subsistence lifestyles, hunting and fishing and gathering berries 
and plants, and receive some monetary assistance from the federal and state 
governments.  The 58 villages comprising the Y-K Delta are not linked by 
road and are accessible only by boat, airplane, or snowmobile.  The majority 
of residents of this region receive their health care from the village based 
community health aides and the Y-K Delta Regional Hospital located in Bethel, 
AK.  Multi-specialty tertiary care is available on referral to the Alaska Native 
Medical Center in Anchorage.  The Y-K Delta Regional Hospital is operated by 
the YKHC, a tribally owned and operated health corporation with a Board of 
elected members representing the communities within the region.
The Obstetrical Unit at the Bethel hospital is staffed by family physicians 
and RNs who manage triage, labor and delivery, postpartum, and the nursery.  
There was an average of 620 births per year from 2000-2003 to Y-K Delta 
women.  Nearly all (96%) of Y-K Delta women are seen for prenatal care at the 
Y-K Delta Regional Hospital, including a prenatal visit at ~36 weeks gestation 
(Patten et al., 2008 in press).  At this visit, the high-risk pregnancies (about 200 
each year) are transferred to the Alaska Native Medical Center in Anchorage.  
The remaining women reside at the Bethel pre-maternal home until delivery 
and continue to have prenatal checks until delivery.  Prenatal providers 
routinely asked about tobacco use, but a system is not in place for referring or 
treating pregnant women who used tobacco.
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The tobacco educational clinical intervention was piloted in 2002 at the 
Nicotine Control and Research Program at the Y-K Delta Regional Hospital.   
The Nicotine Control and Research Program provide self-help materials, 
face-to-face and telephone counseling, along with physician referrals for 
medications to quit tobacco if indicated.
Patients
The educational intervention was piloted over a 10-month period in 2002. 
During this time period, 100 Alaska Native pregnant women received the 
intervention.  There were 549 women seen for their first prenatal visit during 
the time period March 1, 2002 through December 31, 2002.  Based on our 
prior studies examining tobacco use prevalence (Patten et al., 2008 in press), 
we conservatively estimate that 50% or 274 of these women were current 
tobacco users.  Thus, our sample of 100 represents approximately 36% of all 
women tobacco users seen for a prenatal visit during the study period.
Intervention 
Obstetricians or other health care providers at YKHC identified all 
pregnant tobacco users seen for a prenatal visit.  If the patient was interested 
and willing, she was referred to the Nicotine Control and Research Program 
for the intervention.  We did not collect data on the number of women 
approached.  Anecdotal information provided by health care providers 
suggests the most common reasons for non-participation were lack of time or 
interest.
Four trained, female, Alaska Native, bilingual (English and Yupik) nicotine 
dependence counselors in the Nicotine Control and Research Program 
delivered the tobacco educational intervention.  As part of the clinical 
assessment, the counselor conducted a face-to-face interview assessing 
socio-demographics, tobacco use, and tobacco-related health beliefs.  The 
counselor provided advice to stop tobacco use; provided education and 
written materials on the effects of tobacco on the woman and her baby; 
assessed the woman’s readiness to stop tobacco use; and assisted with 
quitting, if desired.  A culturally and pregnancy specific brochure “How 
Does Tobacco Affect My Baby?” and a clinical teaching sheet “Tobacco and 
Pregnancy,” designed by the program staff, were provided to women as part 
of the intervention.  If the woman indicated she used Iqmik, she was given an 
additional brochure entitled “The Dangers of Iqmik Use.”  Furthermore, if the 
woman was ready to quit tobacco, she was given the brochure entitled “Now 
I’m Ready to Quit Nicotine” which described how to quit during pregnancy.  
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This intervention is consistent with an evidenced based intervention 
recommended for all pregnant tobacco users; i.e., the 5A’s (Melvin et al., 2000; 
Fiore et al., 2008).  
Procedure
A retrospective review of the clinical database was performed.   The 
Nicotine Control and Research Program maintain an electronic data base of all 
clinical assessments, which was utilized for purposes of this study.  Variables 
abstracted were socio-demographics, tobacco use characteristics and health 
beliefs which are detailed below (see Measures).  In addition, data were 
abstracted from the woman’s medical record to obtain her tobacco use status 
at the last prenatal visit and at delivery.   
Measures
Prior to the intervention, the counselor assessed baseline socio-
demographics, tobacco use characteristics and tobacco-related health beliefs 
using a structured interview.
Socio-demographics.
 The counselor assessed the patient’s age; education; duration of this 
pregnancy; number of previous pregnancies; primary language; and her 
access to a telephone, television, and VCR/DVD in the home or elsewhere.   
Tobacco use.  
The counselor assessed the type(s) of tobacco used; whether or not the 
woman’s home was smoke-free, prior quit attempts, and whether or not 
tobacco was used during prior pregnancies.  The women were asked the item 
“How soon after you first wake up do you first use tobacco?” with response 
options: within 5 minutes, 6-30 minutes, 31-60 minutes, or over 60 minutes, 
from the Fagerström Tolerance Questionnaire modified for chewers (FTQ-
ST) (Boyle, Jensen, Hatsukami, & Severson, 1995; Thomas et al., 2006).  We 
used the stage of change algorithm (Prochaska & DiClemente, 1992) as a 
measure of readiness to quit.  Patients were asked “Are you planning to stop 
using tobacco for good” with response options: Yes, I’ve already stopped 
(action); Yes, I plan to quit today (preparation); Yes, within the next 30 days 
(preparation); Yes, within the next 6 months (contemplation); or No, I’m not 
planning to stop for good (precontemplation).
Health beliefs.  
Drawing from existing validated measures which assess smoking-related 
health beliefs of pregnant women (Arnold et al., 2001; Haslam & Draper, 
2000), patients were asked “Do you believe that Iqmik is safer to use during 
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pregnancy than commercial chew or cigarette smoking?  If yes, why?” “Do you 
believe tobacco has been harmful to your health? If yes, how?” and “Do you 
have any health concerns about your tobacco use for your baby? If yes, what 
are these?”   
Tobacco use outcomes.  
Data were abstracted from the woman’s medical record to obtain 
information on the date of the last prenatal visit, date of delivery, tobacco 
use status at the last prenatal visit and at delivery, and types of tobacco used 
at these time points.  Tobacco use status was based on patient self-report to 
the obstetrician or other prenatal health care provider as documented in the 
medical record.  Tobacco use was not biochemically confirmed.  
Statistical Methods
Baseline socio-demographics, tobacco use characteristics, and tobacco-
related health belief variables were summarized using mean and standard 
deviation (SD) for continuous variables and percentages for categorical 
variables.  In addition to point estimates, 95% confidence intervals (CI) were 
constructed for health beliefs. Analyses were performed to assess whether 
the baseline variables differed according to the type of tobacco used at the 
time of the intervention, employing Fisher’s exact test for categorical variables 
and the Kruskal-Wallis test for continuous variables. Missing values were 
not included in denominators for percentages or statistical tests.  For these 
analyses, type of tobacco used at the time of the intervention was categorized 
as Iqmik only, commercial ST use only, cigarette smoking only, or use of 
multiple products.  The percentage of women abstinent from all tobacco 
at the last prenatal visit, and at delivery, was summarized using a point 
estimate and 95% CI overall and by type of tobacco used at the time of the 
intervention. In all cases, two-sided tests were used with p-values <0.05 used 
to denote statistical significance.   
The content of the open-ended responses regarding health beliefs (see 
Measures) were coded into categories, and subjected to thematic analysis by 
the first author.  For purposes of triangulation (Lincoln & Guba, 1985), the data 
were independently coded and summarized for the major themes by another 
investigator.  Discrepancies in coding were discussed until consensus was 
reached for the major themes.   
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Results
Baseline Socio-Demographic and Tobacco Use Characteristics
The 100 pregnant women were from 32 different villages on the Y-K Delta. 
Table 1 shows the baseline socio-demographics, tobacco use characteristics, 
and tobacco-related health beliefs, overall and by type of tobacco used at 
the time of the intervention.  The women were on average 25.9±6.2 years of 
age (median 25, range 16-42) and were at 6.3± 2.6 months gestation (median 
7.9, range 0.7 to 8.9) when seen for the educational intervention. Nearly all 
(98%) of the women reported they had a television and VCR/DVD player in 
their home, and 98% had a telephone in their home or had access to one.  All 
currently used tobacco:  56 used Iqmik only, 18 smoked cigarettes only, 13 
used commercial ST use only, and 13 reported multiple products.  For patients 
using multiple products, 6 used Iqmik and commercial ST, 3 used Iqmik and 
smoked cigarettes, 3 used commercial ST and smoked cigarettes, and 1 used 
all 3 products.  None reported current pipe or cigar use.  The proportion of 
patients who used Iqmik only was higher for those who reported Yupik as 
their primary language (86%) compared with those reporting English (14%) 
or Cupik (0%) as their first language (p<0.001).  No other socio-demographic 
characteristics differed significantly by type of tobacco used at the time of the 
intervention.
Table 1. Baseline Socio-demographics, Tobacco Use Characteristics, and 
Tobacco-Related Health Beliefs by Type of Tobacco Used at the Time of 
the Tobacco Educational Intervention among Alaska Native Pregnant 
Women (N=100)
   Type of Tobacco Used at Time of Educational Interventiona 
Variable                     Overall             Cigarettes        Commercial        Iqmik       Multiple        p-valueb 
                                      (n=100)                only                 smokeless            only        Products
                               (n=18)                tobacco            (n=56)       (n=13)
                  only (n=13)                                    
Socio-demographics        
Age, mean ± SD         25.9 ± 6.2           25.4 ± 6.2           24.3 ± 4.2         26.7 ± 6.6      25.2 ± 5.9           0.79 
   median (range)        25 (16-42)       24 (16-42)           25 (19-31)  25 (17-42)     26 (17-36) 
Gestation at 
   intervention, 
   mean ± SD days       192.5 ± 78      198.9 ± 77.5      208.2 ± 71.9     185.2 ± 81.2     202.5 ± 74.6    0.74 
   median (range)         240 (22-269)  244 (33-266)     232 (64-269)    235 (22-268)    245 (67-265) 
Education, 
   mean ± SD  years     10.2 ± 4.0      10.4 ± 4            10.8 ± 3.3           10.2 ± 4      9.6 ± 4.4             0.71
   median (range)         12 (0-15)     12 (0-13)          12 (0-12)             12 (0-15)     11 (0-14) 
Primary language      
   Yup’ik  64 (64)     2 (11.1)            8 (61.5)               48 (85.7)     6 (46.2)        <.0001
   English                      34 (34)   16 (88.9)            4 (30.8) 8 (14.3)     6 (46.2)
   Cupik  2 (2)        0 (0)             1 (7.7)   0 (0)      1 (7.7) 
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Variable                     Overall             Cigarettes        Commercial        Iqmik       Multiple        p-valueb 
                 (n=100)                only                 smokeless            only        Products
                               (n=18)                tobacco            (n=56)       (n=13)
                  only (n=13)                                    
Telephone in home     94 (94)       16 (88.9)               11 (84.6)   54 (96.4)     13 (100)            0.17
   If no, access 
     to telephone    4 (66.7)           1 (50)                   2 (100)     1 (50)         --             --
Television and 
    VCR/DVD in home     98 (98)         17 (94.4)              13 (100)  55 (98.2)    13 (100)            0.69
   If no, access to 
     television & VCR/DVD   0 (0)             0 (0)                        --     0 (0)         --               --
Reported at least one
   previous pregnancy    72 (72)         14 (77.8)              6 (46.2) 43 (76.8)    9 (69.2)           0.18
  Number of prior 
    pregnancies (n=72) 
     mean ± SD  3.1 ± 3.0          2.6 ± 1.9             2.2 ± 3.0  3.4 ± 3.2    3.7 ± 3.4            0.50
     median (range)   3 (0-14)           3 (0-6)                 0 (0-9)  3 (0-14)     4 (0-11) 
Tobacco Use Characteristics      
Smoke-free home  89 (89.0)        16 (88.9)            10 (76.9) 51 (91.1)    12 (92.3)         0.556
Readiness to quit tobacco       
    Precontemplation  54 (56.3)        11 (61.1)            4 (36.4) 33 (61.1)    6 (46.2)           0.24
    Contemplation     9 (9.4)            0 (0)                2 (18.2)  6 (11.1)     1 (7.7) 
    Preparation   30 (31.3)          6 (33.4)            4 (36.4)             15 (27.8)    5 (38.5) 
    Action                          3 (3.1)           1 (5.6)                1 (9.1)    0 (0)     1 (7.7) 
Tobacco use upon awakening       
    Within 5 minutes 12 (12.5)          2 (11.1)              1 (8.3) 5 (9.3)     4 (33.3)          0.57
    6-30 minutes 20 (20.8)          5 (27.8)             4 (33.3)            10 (18.5)     1 (8.3) 
    31-60 minutes 18 (18.8)          4 (22.2)              1 (8.3)              11 (20.4)     2 (16.7) 
    Over 60 minutes 46 (47.9)          7 (38.9)               6 (50) 28 (51.9)     5 (41.7) 
Prior attempts to stop tobacco use       
    0  38 (38.4)          6 (33.3)               6 (50) 23 (41.1)     3 (23.1)            0.79
    1  21 (21.2)          4 (22.2)               1 (8.3) 12 (21.4)     4 (30.8) 
    2 or more 40 (40.4)          8 (44.4)               5 (41.7) 21 (37.5)     6 (46.2) 
Used tobacco during one or more previous 
pregnancies (n=72)c    65 (90.3)         10 (71.4)              3 (50) 43 (100)      9 (100)       <.0001
Number of previous pregnancies in which tobacco was used (n=65) 
   mean ± SD  4.0 ± 2.8        3.1 ± 1.7             5.7 ± 2.9 4.0 ± 3.1    4.4 ± 2.2            0.36
   median (range)  3 (1-14)          3 (1-6)                 4 (4-9)  3 (1-14)      5 (1-8) 
Tobacco-Related Health Beliefsd      
Believes Iqmik is safer to use during   
     pregnancy    11 (11.1)          2 (11.1)                 0 (0) 7 (12.5)      2 (15.4)            0.67
Has health concerns about her tobacco use 
    for her baby    40 (40.4)          8 (44.4)               6 (50) 21 (37.5)      5 (38.5)            0.87
Believes tobacco is harmful to her own
    health      55 (55.6)         11 (61.1)             6 (50) 29 (51.8)       9 (69.2)           0.65
a All values are n (%) except where noted. b  P-values obtained using Fisher’s exact test for 
categorical variables and Kruskal-Wallis test for continuous variables. Missing values not included 
in percentages or statistical tests. c  N is based on number of women reporting a previous 
pregnancy. d  N=99, data on health beliefs were missing for 1 woman.
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About half of the sample (56%) reported they were in the 
precontemplation stage of change to stop tobacco use.  There was no 
statistically significant association detected between patient age and 
readiness to quit tobacco (Spearman’s rank correlation, r = -0.04, p = 0.68).  
Most (72%) of the women reported at least one previous pregnancy, 
with an average of 3 prior pregnancies.  Of the 72 women who reported at 
least one previous pregnancy, 65 (90%) reported they had used tobacco 
during at least one prior pregnancy.   There was a significant difference 
(p<0.001) in the proportion of women reporting they used tobacco during a 
previous pregnancy by type of tobacco used at the time of the intervention 
(100% among women who used Iqmik only or multiple tobacco products, 
71% among those who smoked cigarettes only and 50% among those who 
used commercial ST only).  No other tobacco use characteristics differed 
significantly by type of tobacco used at the time of the intervention.
Baseline Tobacco-Related Health Beliefs
Only 11% (95% CI 6%-19%) of the women believed Iqmik was safer to use 
during pregnancy than other forms of tobacco (see Table 1).  Forty percent 
(95% CI 31%-51%) reported they had health concerns about their tobacco use 
for their baby, and 56% (95% CI 45%-66%) believed that tobacco had been 
harmful to their own health. The proportion of women who believed tobacco 
was harmful to their own health was significantly higher than the percentage 
who believed tobacco use was harmful for their baby (56% vs. 40%, p=0.002).  
Thirty-four percent (34/99) of the women indicated no harmful effects for 
either self or baby, 25% (25/99) believed tobacco was harmful to self but 
not baby, 10% (10/99) reported tobacco was not harmful to self but harmful 
for baby, and 30% (30/99) indicated harmful effects for both self and baby.  
Tobacco-related health beliefs did not significantly differ by type of tobacco 
used at the time of the intervention (Table 1).  Table 2 shows results of the 
qualitative analysis of concerns women reported about using tobacco for 
their own health or for their baby.    
Table 2. Themes and Illustrative Quotes of Tobacco-Related Health Beliefs 
During Pregnancy
Harmful effects of tobacco use during pregnancy for baby
1.  Baby will be born addicted to tobacco
     -born addicted
    - baby born with withdrawals, jerkiness
    - may make baby’s heart beat faster, born with withdrawals
    - the nicotine going to the baby
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2.  Baby will not be healthy 
     - might be born sickly
     - gives baby bad health
     - might not grow, low birth weight 
    - baby might get sick all the time 
3.  Baby will have lung problems
     - less oxygen
     - asthma
     -my baby’s lungs
   - chronic lung disease
Harmful effects of tobacco use during pregnancy for woman’s own health
1.  High blood pressure
2.  Lung or respiratory problems
     -started coughing from cigarettes
     -lungs
     -breathing, get out of breath  
     -bronchitis   
3.  Fatigue
     - get tired too easily
     - don’t play sports as good as I used to, get tired easily
4.  Risk of cancer
     -mouth cancer
     -can cause cancer and high blood pressure
5.  General health 
     - makes me sick
     - dizzy spells
     - doctors tell pregnant women not to chew because it harms baby and 
mother
6.  Appearance related 
    - yes, my teeth (brown stains)
    -  yellow teeth 
     - ruins my teeth
     - bad breath
     - making skin wrinkle
Tobacco Educational Intervention
The average time counselors spent delivering the intervention was 20.2 
± 6.8 minutes (median 20, range 5-45).  There was no significant difference 
in duration of the intervention by type of tobacco used at the time of the 
intervention (p=0.25).  
Follow-Up: Tobacco Use at the Last Prenatal Visit and at Delivery
The time from the date the woman was seen for the educational 
intervention to the last prenatal visit averaged 72.6 days (median 29.5, 
range 0 to 239) and from the last prenatal visit to the time of delivery was 
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9.3 days (median 5, range 0 to 152).  The mean duration from the date of the 
educational intervention to delivery was 77 days (median 30, range 0 to 244).  
These time intervals did not differ significantly by type of tobacco used at the 
time of the educational intervention.
Table 3 shows the tobacco use status at the last prenatal visit and at 
delivery for the 100 women overall and by type of tobacco used at the time 
of the educational intervention.  At the last prenatal visit, 11% (95% CI 6%-
19%) reported they did not use any tobacco product.   At delivery, 12% (95% 
CI 6%-20%) reported abstinence from tobacco.   From inspection of Table 3, 
there were not substantial changes in type of tobacco used over time.  For 
example, among the 56 reporting Iqmik only at the time of the educational 
intervention, 88% and 87% used Iqmik only at the last prenatal visit and at 
delivery, respectively.     
Table 3. Tobacco Use at the Last Prenatal Visit and at Delivery by Type of 
Tobacco Used at the Time of the Tobacco Educational Intervention among 
Alaska Native Pregnant Women (N=100)
    Type of Tobacco Used at Time of Educational Interventiona 
Variable                     Overall             Cigarettes        Commercial        Iqmik        Multiple       p-valueb 
                                      (n=100)                only                 smokeless            only         Products
                               (n=18)                tobacco            (n=56)       (n=13)
                  only (n=13)                                    
Used tobacco at last prenatal 
    visit   89 (89)      14 (77.8)          12 (92.3) 51 (91.1)   12 (92.3)        0.44
Type of tobacco use at last prenatal visit        <.0001
    None                  11 (11)         4 (22.2)             1 (7.7)   5 (8.9)     1 (7.78) 
    Cigarettes      14 (14)       13 (72.2)             0 (0)   0 (0)     1 (7.7) 
    Commercial chew  14 (14)           0 (0)                8 (61.5)   2 (3.6)     4 (30.8) 
    Iqmik       61 (61)          1 (5.6)             4 (30.8) 49 (87.5)     7 (53.8) 
    Multiple products     0 (0)            0 (0) 0 (0)    0 (0)       0 (0) 
Used tobacco 
  at delivery                 88 (88)      14 (77.8)         11 (84.6)        51 (91.1)   12 (92.3)          0.42
Type of tobacco use at delivery (n=98)         <.0001
    None   12 (12.2)         4 (22.2)          2 (15.4) 5 (9.1) 1 (8.3) 
    Cigarettes   14 (14.3)       13 (72.2) 0 (0)  0 (0) 1 (8.3) 
    Commercial chew  14 (14.3)          0 (0)             9 (69.2)         2 (3.6) 3 (25.0) 
    Iqmik    58 (59.2)          1 (5.6)            2 (15.4)       48 (87.3) 7 (58.3) 
   Multiple products      0 (0)           0 (0)                  0 (0) 0 (0)     0 (0) 
a All values are n (%) except where noted.  b  P-values derived from Fisher’s exact test.  
Missing values are not included in denominators for percentages or statistical tests. 
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Discussion
This program evaluation was one step toward developing a tobacco 
cessation referral system and intervention that can be routinely implemented 
during prenatal care for Alaska Native pregnant women residing in Western 
Alaska.  Our evaluation of this pilot clinical program addresses a priority 
among the Alaska Native people, specifically the health and welfare of 
the children (Renner et al., 2004).  Together with YKHC and ANTHC, we 
committed to a long-term plan to address tobacco use among pregnant 
women and children (Enoch & Patten, 2004; Renner et al., 2004).  Permanent 
implementation of the methods piloted in our educational intervention will 
require substantial system and policy changes involving extensive planning 
(Windsor, Dalmat, Orleans, & Gritz, 1990; Windsor et al., 2000).  
The mean duration of time spent by the counselor with each woman in 
our educational intervention was 20 minutes.  This supports the feasibility of 
delivering a face-to-face tobacco educational intervention at a prenatal visit.  
However, even briefer (i.e., 5-10 minutes) interventions at the first prenatal 
visit incorporating the 5 A’s have been shown to enhance tobacco abstinence, 
and are considered state-of-the art for pregnant women (Fiore et al., 2008; 
Melvin et al., 2000; Windsor et al., 2000).  Less time-intensive interventions (for 
both patients and practitioners) may also allow more women to participate.  
Nonetheless, the optimal duration of time needed for effective intervention 
needs further study.  
The abstinence rates at the last prenatal visit (11%) and at delivery (12%) 
were minimal, suggesting the need to augment the tobacco educational 
intervention to increase this rate.  We did not include a control group and 
therefore are not able to characterize the spontaneous rate of cessation in this 
population.  Among non-Alaska Native pregnant women who report cigarette 
smoking at the first prenatal visit, the spontaneous rate of cessation (i.e., 
without treatment) assessed at the end of pregnancy is estimated to be 0%-
17% (Mullen, 1999; Windsor et al., 1998).  Thus, there is a need to identify more 
effective interventions for Alaska Native pregnant women. For example, the 
intervention could be supplemented with a video or telephone counseling 
as we learned that nearly all women had access to a television and DVD/VCR, 
and telephone. 
Our study also reports new findings on the health beliefs related to 
tobacco use during pregnancy that have not been previously reported 
for Alaska Native women.  Compared with previous studies of non-Alaska 
Native pregnant women who smoked cigarettes (Arnold et al., 2001; Dunn 
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et al., 1998; Gawley & Cupples, 2002; Lelong et al., 1995; Walsh et al., 1997), 
we found a much lower proportion of women who believed that tobacco 
was harmful to the fetus (range 61-93% in prior reports vs. 40% in our 
study).  Moreover, the percentage of women who reported health concerns 
about their tobacco use for their baby was significantly lower than for the 
proportion indicating concerns for their own health (40% vs. 56%).  The 
health effects of smoking during pregnancy have been well publicized in the 
general U.S. population.  Our findings suggest that similar efforts are needed 
to educate Alaska Native women about the health effects of tobacco use even 
prior to pregnancy.  Table 2 offers some insights into concerns women have 
that could be emphasized in such educational efforts, but also highlights 
areas where education may be helpful, for example, concerns about tobacco 
use on pregnancy outcomes were not mentioned.  
Unexpectedly, very few (11%) of the women reported they believed that 
Iqmik was safer to use during pregnancy than other forms of tobacco.  Our 
qualitative work (Renner, Enoch et al., 2005; Renner et al., 2004), conducted 
during the same time period, indicated a low level of knowledge about the 
health risks of Iqmik use during pregnancy.  However, it is likely that our 
current sample may not be representative of pregnant women in the region.  
Selection bias could have occurred if participation varied by education or 
knowledge regarding the health risks of tobacco use during pregnancy, 
or motivation to quit tobacco use.  Those referred and who agreed to 
participate may have been more knowledgeable about health risks.  Indeed, 
our sample represents only about a third of all pregnant tobacco users seen 
for a prenatal visit during the pilot intervention period.  In addition, we do 
not have information on whether or not the prenatal health care provider 
told the woman about the risks of tobacco, or Iqmik specifically, prior to 
being referred and seen for the educational intervention. Provider education 
may have influenced the health beliefs at the time of interview.  Related to 
this, the women in our sample were seen for the intervention relatively late 
in pregnancy and health beliefs may differ earlier in pregnancy.  Thus, our 
findings on tobacco-related health beliefs should be interpreted within the 
context of our sample and the care delivery model.
Another limitation of this study is the small sample size.  Moreover, 
because this pilot educational intervention was implemented as a clinical 
service, we did not obtain biochemical verification of abstinence.  As such, 
our tobacco abstinence rates may be an overestimate.  Based on biochemical 
confirmation, the non-disclosure rates of cigarette smoking are as high as 23% 
among pregnant women (Windsor et al., 2000).  However, our previous pilot 
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study with Alaska Native pregnant women (Hurt et al., 2005) found that all 
women self-reporting tobacco abstinence were found to have non-detectable 
concentrations of serum cotinine (a metabolite of nicotine), confirming the 
self-report data.  Another drawback is that we did not assess the various 
behavioral and pharmacological treatments for tobacco use that patients may 
have received subsequent to the educational intervention nor tobacco use 
status post-partum.
Recommendations for Future Research
This study suggests several directions for future research.  Prior studies 
suggest that tobacco-related health beliefs are not highly correlated with 
smoking cessation.  Because health beliefs were assessed late in pregnancy 
and all women continued to use tobacco, we do not know the impact of 
health beliefs on cessation in this population.  More women had health 
concerns about tobacco use during pregnancy for their own health than for 
their baby.  Perhaps education on the health effects of tobacco use may be 
effective as one component of a tobacco cessation intervention, especially 
if delivered earlier in pregnancy or even pre-pregnancy.   Moreover, the 
development, implementation, and evaluation of the feasibility and efficacy 
of culturally relevant interventions are needed to enhance the tobacco 
abstinence rate.  In particular, the results from a treatment efficacy study 
could support the basis for a system change in the delivery of a tobacco use 
intervention at the first prenatal visit.
References
Acharya, G., Jauniaux, E., Sathia, L., Griffin, M., & Morgan, H. (2002). Evaluation 
of the impact of current antismoking advice in the UK on women with 
planned pregnancies. Journal of Obstetric Gynecology, 22(5), 498-500.
Alaska Humanities Forum (2003). A Survey on Native Perspectives on Alaska 
Issues. Anchorage, AK
Arnold, C. L., Davis, T. C., Berkel, H. J., Jackson, R. H., Nandy, I., & London, S. 
(2001). Smoking status, reading level, and knowledge of tobacco effects 
among low-income pregnant women. Preventive Medicine, 32(4), 313-320. 
Blanchette, R. (2001). Fungus ashes and tobacco: the use of Phellinus igniarius 
by the indigenous people of North America. Mycologist, 15, 4-9. 
Boyle, R. G., Jensen, J., Hatsukami, D. K., & Severson, H. H. (1995). Measuring 
dependence in smokeless tobacco users. Addictive Behaviors, 20(4), 443-
450. 
48 Journal of Health Disparities Research and Practice  •  Vol. 2, No. 3  •  Fall 2008
Dunn, C. L., Pirie, P. L., & Lando, H. A. (1998). Attitudes and perceptions related 
to smoking among pregnant and postpartum women in a low-income, 
multiethnic setting. American Journal of Health Promotion, 12(4), 267-274. 
Enoch, C., & Patten, C. A. (2004). Focus groups of Y-K Delta-Alaska Natives:  
Attitudes toward tobacco use and cessation. Paper presented at the Alaska 
Native Health Research Conference.  
Fiore, M. C., Jaen, C. R., Baker, T.B., et al.  (2008). Treating tobacco use and 
dependence:  2008 update.  Clinical Practice Guideline.  Rockville, MD: U.S. 
Department of Health and Human Services.  Public Health Service. 
Gawley, S., & Cupples, M. E. (2002). Smoking in pregnancy--the size of our 
challenge. Ulster Medical Journal, 71(1), 17-21. 
Haslam, C., & Draper, E. (2000). Stage of change is associated with assessment 
of the health risks of maternal smoking among pregnant women. Social 
Science & Medicine, 51(8), 1189-1196. 
Haslam, C., Draper, E. S., & Goyder, E. (1997). The pregnant smoker: a 
preliminary investigation of the social and psychological influences. 
Journal of Public Health Medicine, 19(2), 187-192. 
Hurt, R. D., Renner, C. C., Patten, C. A., Ebbert, J. O., Offord, K. P., Schroeder, 
D. R., et al. (2005). Iqmik--a form of smokeless tobacco used by pregnant 
Alaska natives: nicotine exposure in their neonates. Journal of Maternal 
Fetal Neonatal Medicine, 17(4), 281-289. 
Lelong, N., Kaminski, M., Chwalow, J., Bean, K., & Subtil, D. (1995). Attitudes 
and behavior of pregnant women and health professionals towards 
alcohol and tobacco consumption. Patient Education & Counseling, 25(1), 
39-49. 
Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic Inquiry. Beverly Hills, CA: SAGE.  
Lumley, J., Oliver, S. S., Chamberlain, C., & Oakley, L. (2004). Interventions for 
promoting smoking cessation during pregnancy. Cochrane Database Syst 
Reviews, (4), CD001055, retrieved from: http://mrw.interscience.wiley.com/
cochrane/clsysrev/articles/CD001055/frame.html. Accessed Mar 30, 2007. 
Martin, J., Hamilton, B., Ventura, S., Menacker, F., & Park, M. (2002). Births:  final 
data for 2000. National Vital Statistics Reports, 50, 1-104,  
Melvin, C., & Gaffney, C. (2004). Treating nicotine use and dependence of 
pregnant and parenting smokers: an update. Nicotine Tobacco & Research, 
6 Suppl 2, S107-124. 
Melvin, C. L., Dolan-Mullen, P., Windsor, R. A., Whiteside, H. P., Jr., & Goldenberg, 
R. L. (2000). Recommended cessation counseling for pregnant women who 
smoke: a review of the evidence. Tobacco Control, 9 Suppl 3, III80-84. 
Mullen, P. D. (1999). Maternal smoking during pregnancy and evidence-based 
intervention to promote cessation. Primary Care, 26(3), 577-589.
 49Tobacco Education Intervention for Pregnant Alaska Native Women  •  Patten et al.
Patten, C. A., Renner, C. C., Decker, P. A., O’Campo, E., Larsen, K., Enoch, C., et al. 
(2008). Tobacco Use and Cessation Among Pregnant Alaska Natives from 
Western Alaska Enrolled in the WIC Program, 2001-2002, Maternal and 
Child Health Journal; 12 (Suppl 1); 30-6. 
Prochaska, J. O., & DiClemente, C. C. (1992). Stages of change. In M. Hersen, R. 
Eisler & P. Miller (Eds.), Progress in Behavioral Modification. New York, NY: 
Sycamore Publications. 
Renner, C. C., Enoch, C., Patten, C. A., Ebbert, J. O., Hurt, R. D., Moyer, T. P., et al. 
(2005). Iqmik: a form of smokeless tobacco used among Alaska natives. 
American Journal of Health Behaviors, 29(6), 588-594. 
Renner, C. C., Patten, C. A., Day, G. E., Enoch, C. C., Schroeder, D. R., Offord, K. 
P., et al. (2005). Tobacco use during pregnancy among Alaska Natives in 
western Alaska. Alaska Medicine, 47(1), 12-16. 
Renner, C. C., Patten, C. A., Enoch, C., Petraitis, J., Offord, K. P., Angstman, S., 
et al. (2004). Focus groups of Y-K Delta Alaska Natives: attitudes toward 
tobacco use and tobacco dependence interventions. Preventive Medicine, 
38(4), 421-431. 
Substance Abuse and Mental Health Services Administration.  (2006).  Results 
from the 2005 National Survey on Drug Use and Health: National Findings.  
Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 
06-4194.  Rockville, MD.  
Thomas, J. L., Ebbert, J. O., Patten, C. A., Dale, L. C., Bronars, C. A., & Schroeder, 
D. R. (2006). Measuring nicotine dependence among smokeless tobacco 
users. Addictive Behaviors, 31(9), 1511-1521.
U.S. Department of Health and Human Services.  (2001). Women and smoking. 
Report of the Surgeon General. Rockville, MD. 
Walsh, R. A., Redman, S., Brinsmead, M. W., & Fryer, J. L. (1997). Predictors of 
smoking in pregnancy and attitudes and knowledge of risks of pregnant 
smokers. Drug and Alcohol Reviews, 16(1), 41-67. 
Windsor, R. A., Boyd, N. R., & Orleans, C. T. (1998). A meta-evaluation of 
smoking cessation intervention research among pregnant women: 
improving the science and art. Health Education Research, 13(3), 419-438. 
Windsor, R. A., Dalmat, M. E., Orleans, C. T., & Gritz, E. R. (1990). The handbook 
to plan, implement and evaluate smoking cessation programs for 
pregnant women. White Plains, NY. 
Windsor, R. A., Woodby, L. L., Miller, T. M., Hardin, J. M., Crawford, M. A., & 
DiClemente, C. C. (2000). Effectiveness of Agency for Health Care Policy 
and Research clinical practice guideline and patient education methods 
for pregnant smokers in Medicaid maternity care. American Journal of 
Obstetrics & Gynecology, 182(1 Pt 1), 68-75.
50 Journal of Health Disparities Research and Practice  •  Vol. 2, No. 3  •  Fall 2008
Christi A. Patten, Ph.D., Mayo Clinic Rochester, MN
Carrie Enoch, R.H.S., Yukon-Kuskokwim Health Corporation, Bethel, AK
Caroline C. Renner, M.P.H., Alaska Native Tribal Health Consortium, Office 
of Alaska Native Health Research, Anchorage, AK
Karin Larsen, Ph.D., Mayo Clinic, Rochester, MN
Paul A. Decker, M.S., Mayo Clinic, Rochester, MN
Kari J. Anderson, M.S., Mayo Clinic, Rochester, MN
Caroline Nevak, Yukon-Kuskokwim Health Corporation, Bethel, AK
Ann Glasheen, Yukon-Kuskokwim Health Corporation, Bethel, AK
Kenneth P. Offord, M.S., Mayo Clinic, Rochester, MN
Anne Lanier, Ph.D., Alaska Native Tribal Health Consortium, Office of Alaska 
Native Health Research,  Anchorage, AK
Corresponding Author:  Christi A. Patten, 200 First St. SW, Charlton 6-273, 
Rochester, MN, 55901, phone number: (507) 538-7370; fax number (507) 266-
2478 email: patten.christi@mayo.edu
